ArticleCancer research communications2026

Development of Glypican 3-Targeting Antibody-Drug Conjugates for Hepatocellular Carcinoma Therapy.

Ning Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.